The failure of the D2R antagonist to inhibit the effects of TA on colitis induction may be related to the narrow effective range of the D2R antagonist on TA-mediated modulation of cytokine secretion by immune cells in vitro; it may be difficult to achieve an effective concentration of D2R antagonist in vivo. Here, DRD2 is linked to colitis.